Development and validation of a nomogram to predict the risk of potentially inappropriate medication use in older lung cancer outpatients with multimorbidity.
Fangyuan TianZhaoyan ChenBin WuPublished in: Expert opinion on drug safety (2023)
The nomogram could be a convenient, intuitive, and personalized clinical tool for assessing the risk of PIM in older lung cancer outpatients.